MNMD

Mind Medicine (MindMed) Inc. is a healthcare company operating in the biotechnology industry with a significant presence, boasting a market capitalization of $1.32B and employing 74 individuals. The company's financial health paints a picture of substantial losses, with net income totaling -$168,098,000 and EBITDA at -$151,672,752 over the trailing twelve months. Furthermore, free cash flow amounts to -$47,703,376, highlighting liquidity concerns. Notably, MindMed Inc.'s balance sheet shows a relatively manageable debt-to-equity ratio of 31.38, although the company's profitability is severely impacted, with gross margin, operating margin, and profit margin all at 0.0%. Returns on equity (-85.6%) and assets (-33.9%) are also negative. MindMed Inc.'s valuation context is marked by a forward P/E ratio of -7.66, indicating significant losses relative to its market capitalization. The price-to-book ratio stands at 7.98, while the EV/EBITDA ratio is equally unflattering at -7.75.